about
Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical EndocrinologistsSparse labeling of proteins: structural characterization from long range constraintsStructural Asymmetry in the Closed State of Mitochondrial Hsp90 (TRAP1) Supports a Two-Step ATP Hydrolysis MechanismGene therapy of carcinoma using ultrasound-targeted microbubble destructionUltrasound-targeted microbubble destruction to deliver siRNA cancer therapy.Vascular endoluminal delivery of mesenchymal stem cells using acoustic radiation force.Quantification of plaque neovascularization using contrast ultrasound: a histologic validationMortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS).High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapyDialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease.Validation of a laser-assisted wound measurement device for measuring wound volume.Validation of a laser-assisted wound measurement device in a wound healing model.Negative Pressure Wound Therapy With Low Pressure and Gauze Dressings to Treat Diabetic Foot Wounds.Cross-monomer substrate contacts reposition the Hsp90 N-terminal domain and prime the chaperone activityMind the gap: disparity between research funding and costs of care for diabetic foot ulcersFactors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey.Virtualizing the assessment: a novel pragmatic paradigm to evaluate lower extremity joint perception in diabetes.Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes.The economics of limb salvage in diabetes.Conformational dynamics of the molecular chaperone Hsp90Effectiveness and safety of elective surgical procedures to improve wound healing and reduce re-ulceration in diabetic patients with foot ulcers.A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot.Expert opinion on the management of infections in the diabetic foot.Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients.Approaches to learning for the ANZCA Final Examination and validation of the revised Study Process Questionnaire in specialist medical training.Negative-pressure wound therapy with instillation: international consensus guidelines.Electrical stimulation to accelerate wound healing.Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy.Current concepts in the surgical management of acute diabetic foot infections.What's new in the literature: an update of new research since the original WHS diabetic foot ulcer guidelines in 2006.Fracture healing and biomarker expression in a diabetic Zucker rat model.Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infectionsMultidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia.Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.Risk factors for developing osteomyelitis in patients with diabetic foot wounds.Accuracy and durability of Semmes-Weinstein monofilaments: what is the useful service life?Scalable printed electronics: an organic decoder addressing ferroelectric non-volatile memory.Modulation of pre-capillary arteriolar pressure with drag-reducing polymers: a novel method for enhancing microvascular perfusionA novel hydrodynamic method for microvascular flow enhancement.Randomised clinical trial to compare total contact casts, healing sandals and a shear-reducing removable boot to heal diabetic foot ulcers.
P50
Q24650016-E7B7B019-67F6-4C93-9A44-7296FD65098AQ27014556-A8BF5961-51FA-4E82-807B-9016BF89D51CQ27681454-ABC40B5E-91EA-457D-95F2-74B3C4EA7336Q30434291-5970B34A-AE6C-4C9F-A529-085CCCCC037AQ30446500-1D531607-11C0-45BC-ADCB-DD2C015E6BA9Q30468203-B58AA9BC-2611-4766-BB45-81BD540F3738Q30469949-31E1EED7-BD26-4B01-8D52-83EE47153ED7Q33481747-D6EEE293-D683-42A5-8E7E-A5D5C39A4FA2Q33751580-69C6B76C-07D6-4BE2-AA57-16B90E7B7137Q34016073-92F46751-31C9-4368-8093-34F57FC88F32Q35017247-5BDEB4AA-65AE-4FCE-B630-7D3B2DB8D5B5Q35225249-0B87D06C-F4ED-4CBD-AEA7-73D9D0751E08Q35682708-476A0B14-30BF-4354-AE57-BEAD4F33383AQ35764464-C73A8E33-7F0A-46EC-AA6D-E8879EFF613EQ36942111-1AE0426C-10B9-4513-BB44-2605D3049440Q37174287-21CC32E9-2801-4ADA-A196-2FB8F6A10ACEQ37639001-01781722-1C75-4B01-A0AD-87CC771B2997Q37737895-F2147C3B-C469-4B12-A536-AB817589C00FQ37825760-2A24EF17-9BA4-4D0B-B7E4-5ACE081D78A1Q37854116-F0529489-42BA-4168-8ECA-4D8552A7325CQ37978274-64C3A316-514D-4DE5-96CB-A3E75073B994Q37978286-BC814194-DC5D-405B-8DBF-EAFE8DD553A0Q37978287-A083FC17-0D96-4080-BF75-CF460C8F2940Q38053351-C4CE39A8-5F2E-4F2B-A19A-439571B9E72EQ38131531-B8E7324F-4BAB-4979-8B3E-299243D6A809Q38134255-7DD83586-CE01-4255-9F93-32C9423B724EQ38139396-77442133-F826-41A2-9655-9E2281C7F9A7Q38152481-FCB1169B-6133-4207-8731-4BE446F722D0Q38231098-457EC6DA-0BF7-473E-9B72-8082F2869E5CQ38241452-BAD9F4EF-F52F-4FD8-A0CA-A7AC570B04EFQ38447437-4E7D5E18-C983-499A-99F9-7589DD138A16Q38718914-ABD7ED4C-A7D5-4D57-A20B-2706892A48E8Q39151837-A5484EDF-D441-47CD-AEB9-6EEB5D3707B9Q39236644-F23EBF11-1E46-4BE9-ABEF-796B46C66C89Q39867831-8C12579C-4858-4A94-8963-9D14660C3254Q40034197-95BA975B-CB63-47F8-A413-FB8E0F75A54EQ40057316-41724C31-CBC2-4703-AA1D-10725E9DA1A2Q40573872-33D16F11-BE25-4A1F-B801-9E90C0C149A5Q43282840-B08884F6-13B6-4353-8E2B-BC2CE09A748EQ44902188-D45470EA-92D1-40D1-8D48-ABE494338572
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lawrence A Lavery
@ast
Lawrence A Lavery
@en
Lawrence A Lavery
@es
Lawrence A Lavery
@nl
Lawrence A Lavery
@sl
type
label
Lawrence A Lavery
@ast
Lawrence A Lavery
@en
Lawrence A Lavery
@es
Lawrence A Lavery
@nl
Lawrence A Lavery
@sl
prefLabel
Lawrence A Lavery
@ast
Lawrence A Lavery
@en
Lawrence A Lavery
@es
Lawrence A Lavery
@nl
Lawrence A Lavery
@sl
P106
P21
P31
P496
0000-0002-7920-9952